Arvinas Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include Foghorn Therapeutics.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
Foghorn Therapeutics
Foghorn Therapeutics
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
Founding Date
Founding Date
2018
Founding Date
2016
Type
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Locations
Cambridge, US HQ
Cambridge, US
Employees
Employees
188
Employees
16135% increase
Valuation ($)
Valuation ($)
243.3 m
Valuation ($)
452 m

Financial

Revenue (est.)
Revenue (est.)
$130k (FY, 2023)
Revenue (est.)
$34.2m (FY, 2023)
Net income
Net income
($234.6m) (FY, 2023)
Net income
($98.4m) (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

Foghorn Therapeutics
HQ
Cambridge, US
Employees
161↑ 35% increase

Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.

View company